1. Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel. (September 2014) Authors: Petri, M; Bechtel, B; Dennis, G; Shah, M; McLaughlin, T; Kan, H; Molta, C Journal: Lupus Issue: Volume 23:Number 10(2014) Page Start: 1006 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0153 Comparison of cardiovascular risk in patients with rheumatoid arthritis treated with biologics versus methotrexate: results at 24-months of follow-up. (15th June 2017) Authors: Khraishi, M; Stutz, M; Lewis, A; Molta, C; Rampakakis, E Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 539 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0506 Hla profiles and their associations with disease phenotypes in a canadian psoriatic arthritis (PSA) cohort. (15th June 2017) Authors: Khraishi, M; Molta, C; Khraishi, Z; Lewis, AM Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care. (June 2016) Authors: Bruce, I N; Urowitz, M; van Vollenhoven, R; Aranow, C; Fettiplace, J; Oldham, M; Wilson, B; Molta, C; Roth, D; Gordon, D Journal: Lupus Issue: Volume 25:Number 7(2016) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA. (11th January 2016) Authors: Collins, C E; Dall'Era, M; Kan, H; Macahilig, C; Molta, C; Koscielny, V; Chang, D J Journal: Lupus science & medicine Issue: Volume 3(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0115 Effect of biological disease modifying anti-rheumatic drugs (BDMARDS) on cardio vascular disease (CVD) risk in ra patients:three years results from a canadian cohort. (15th June 2017) Authors: Khraishi, M; Molta, C; Lewis, A Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 812 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗